Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 11/30/18 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/28/18 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/23/18 | 8-K | Current report filing |
|
4 | |
| 11/16/18 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/14/18 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
51 |
| 11/13/18 | 8-K | Current report filing |
|
13 | |
| 11/08/18 | 8-K | Current report filing |
|
7 | |
| 09/28/18 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/12/18 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/05/18 | EFFECT | Notice of Effectiveness |
|
1 |
